The increase in forecast revenue of almost $19 million is driven by high levels of Chinese demand for the popular a2 Platinum infant formula.
To meet demand a2 has been working with manufacturing partner Synlait Milk to increase production of the infant formula for the remainder of FY17.
The increased demand can be attributed to an extra $9.5 million a2 spent on marketing during the second half of this financial year, used predominantly to sell directly to Chinese buyers.
One of the main reasons for the increase in sales is attributed to the Chinese custom called "daigou" where products are purchased by buyers in Australia, sent to China, and on-sold in China to customers for an inflated price.
A2 has also been pushing the infant formula product through online Chinese retailers as well as mother and baby stores in China.
The price of A2M shares are up 8.66 per cent this morning to $3.64.
This latest announcement from a2 puts the company in a strong position against its main competitor, Bellamy's (ASX: BAL), who yesterday announced strong results from a round of capital raising.
Bellamy's generated $14.3 million from the institutional component of its capital raising which the Company will put towards a major overhaul of its operations.
Never miss a story: Sign up to Business News Australia's free news updates
Follow us on Twitter, Facebook, LinkedIn and Instagram
Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support